BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32405109)

  • 1. Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.
    Chen L; Zhang B; Ti MN; Yang K; Zou Y; Zhang S
    J Infect; 2020 Aug; 81(2):e82-e84. PubMed ID: 32405109
    [No Abstract]   [Full Text] [Related]  

  • 2. Mobile X-rays are highly valuable for critically ill COVID patients.
    Wu G; Li X
    Eur Radiol; 2020 Sep; 30(9):5217-5219. PubMed ID: 32405750
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
    Fox TA; Troy-Barnes E; Kirkwood AA; Chan WY; Day JW; Chavda SJ; Kumar EA; David K; Tomkins O; Sanchez E; Scully M; Khwaja A; Lambert J; Singer M; Roddie C; Morris EC; Yong KL; Thomson KJ; Ardeshna KM
    Br J Haematol; 2020 Nov; 191(3):505-506. PubMed ID: 33103782
    [No Abstract]   [Full Text] [Related]  

  • 4. Critically ill patients with COVID-19 and candidaemia: We must keep this in mind.
    Agrifoglio A; Cachafeiro L; Figueira JC; Añón JM; García de Lorenzo A
    J Mycol Med; 2020 Dec; 30(4):101012. PubMed ID: 32651137
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
    Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
    Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive care.
    Mégarbane B; Tadayoni R
    Occup Environ Med; 2020 Aug; 77(8):584-585. PubMed ID: 32467314
    [No Abstract]   [Full Text] [Related]  

  • 7. Impactful Policy Action to Reduce Drug Costs in Managing Critically Ill Patients with COVID-19.
    Tichy EM; Francis JR
    Mayo Clin Proc; 2020 Aug; 95(8):1808-1809. PubMed ID: 32753159
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.
    Corrêa TD; Matos GFJ; Bravim BA; Cordioli RL; Garrido ADPG; Assuncao MSC; Barbas CSV; Timenetsky KT; Rodrigues RDR; Guimarães HP; Rabello Filho R; Lomar FP; Scarin FCC; Batista CL; Pereira AJ; Guerra JCC; Carneiro BV; Nawa RK; Brandão RM
    Einstein (Sao Paulo); 2020; 18():eCE5931. PubMed ID: 32785567
    [No Abstract]   [Full Text] [Related]  

  • 9. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
    Buetti N; Mazzuchelli T; Lo Priore E; Balmelli C; Llamas M; Pallanza M; Elzi L; Consonni V; Trimboli P; Forni-Ogna V; Bernasconi E
    J Infect; 2020 Aug; 81(2):e148-e149. PubMed ID: 32512022
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Zhang J; Wang H; Dong L
    Telemed J E Health; 2020 Jul; 26(7):853-854. PubMed ID: 32315253
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of critically ill patients with COVID-19 in New York City.
    Piovani D; Bonovas S
    Lancet; 2020 Oct; 396(10257):1064. PubMed ID: 33038958
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019.
    Ji F; Li L; Li Z; Jin Y; Liu W
    Stem Cells Transl Med; 2020 Jul; 9(7):813-814. PubMed ID: 32320535
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features of critically ill patients with confirmed COVID-19.
    Chu Y; Li T; Fang Q; Wang X
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32360498
    [No Abstract]   [Full Text] [Related]  

  • 14. Best practice statements and recommendations for caring for critically ill patients with COVID-19.
    Dugar SP; Vallabhajosyula S
    Ann Intern Med; 2020 Jun; 172(12):JC62. PubMed ID: 32539521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.
    Pallotto C; Suardi LR; Esperti S; Tarquini R; Grifoni E; Meini S; Valoriani A; Di Martino S; Cei F; Sisti E; Piani F; Botta A; Salomoni E; Baragli F; Blanc P
    Infect Dis (Lond); 2020 Sep; 52(9):675-677. PubMed ID: 32543971
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of critically ill patients with COVID-19 in New York City - Authors' reply.
    Cummings MJ; O'Donnell MR
    Lancet; 2020 Oct; 396(10257):1064. PubMed ID: 33038960
    [No Abstract]   [Full Text] [Related]  

  • 17. Aerosol Barrier Hood for Use in the Management of Critically Ill Adults With COVID-19.
    Martel ML; Reardon RF
    Ann Emerg Med; 2020 Sep; 76(3):370-371. PubMed ID: 32534831
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to "Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis".
    Nieuwenhuis MB; Van Biesen S; Juffermans NP
    Crit Care; 2020 Sep; 24(1):591. PubMed ID: 32993744
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic complications in critically ill patients with COVID 19.
    Rosen RJ
    Thromb Res; 2020 Jul; 191():56. PubMed ID: 32388068
    [No Abstract]   [Full Text] [Related]  

  • 20. Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.
    Shobiye DM; Zhang J; Fok L; Zhao Y; Sun J; Xu Z
    Obstet Gynecol; 2020 Sep; 136(3):636-637. PubMed ID: 32826587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.